Institut Du Cancer De Montpellier - Val D'aurelle

This phase 3 trial tests whether combining regorafenib with irinotecan helps people with metastatic colorectal cancer live longer than regorafenib alone. The study includes 377 patients whose cancer has progressed after standard treatments. The goal is to see if the combination i…

This study tests whether a device called Calypso, which tracks the prostate's position in real time during radiation, can reduce long-term side effects compared to standard image-guided radiation. 74 men with low- or intermediate-risk prostate cancer took part. The goal is to see…

This study looks at whether adding a stronger dose of radiation to the tumor site after whole-breast radiation helps prevent breast cancer from returning. About 2004 women with a very early form of breast cancer called DCIS took part. All had breast-conserving surgery and whole-b…

This study looks at giving a single dose of radiation directly to the tumor site during breast-conserving surgery, instead of weeks of whole-breast radiation. It involves women aged 60 and older with small, early-stage, hormone-sensitive breast cancers that have a good outlook. T…

This study tests whether adding a special chemotherapy spray (PIPAC) directly into the abdomen to standard IV chemo can help people with a rare cancer of the belly lining (peritoneal mesothelioma) live longer. About 66 adults who have not had prior treatment will be randomly assi…

This study is testing a new way to analyze thyroid nodules that look suspicious but not clearly cancerous. Researchers are checking if a set of microRNA molecules can better predict which nodules are actually cancer. The goal is to help patients avoid unnecessary surgery. The stu…

This study tests whether adding a special yoga and physiotherapy program to standard care can lower stress in women receiving brachytherapy for cervical cancer. About 98 women will take part. The program includes gentle movement and breathing exercises designed to be safe during …